Drug profile · INN
cetuximab sarotalocan sodium
AKALUX
cetuximab sarotalocan sodium (AKALUX) is a cell membrane disrupting agent.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — cetuximab sarotalocan sodium
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
cetuximab sarotalocan sodium (AKALUX) is a cell membrane disrupting agent.
Key facts
INN cetuximab sarotalocan sodium
Brand AKALUX
Mechanism Cell membrane disrupting agent
Target Cell membrane
Mechanism of action
Cell membrane disrupting agent
Primary target: Cell membrane
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is cetuximab sarotalocan sodium?
cetuximab sarotalocan sodium (AKALUX) is a cell membrane disrupting agent.
What is the brand name for cetuximab sarotalocan sodium?
AKALUX is a marketed brand name for cetuximab sarotalocan sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.